Genetics

'CRISPR-Gold' fixes Duchenne muscular dystrophy mutation in mice

Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR-Cas9 gene-editing technology inside cells and have demonstrated in mice that the technology can repair the mutation that causes ...

Diseases, Conditions, Syndromes

First targeted treatment success for Duchenne Muscular Dystrophy

(Medical Xpress) -- A team led by scientists at UCL, funded by the Medical Research Council (MRC) and AVI BioPharma, have made an important breakthrough in the development of a treatment for Duchenne Muscular Dystrophy (DMD).

page 3 from 13